Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Early Use of Methylene Blue on Hemodynamics in Septic Shock

NCT04970602 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT04970602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04970602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Early Use of Methylene Blue on Hemodynamics in Septic Shock
Lead sponsor
Xiangya Hospital of Central South University
Phase
Not applicable
Overall status
Unknown status
Start date
June 20, 2021
Completion date
January 1, 2024
Enrollment
106 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock